spec sheet11 rows
Benztropine (marketed as Cogentin) is a synthetic tropane used medically for parkinsonism and for the drug-induced extrapyramidal symptoms produced by antipsychotics. It acts principally as a muscarinic acetylcholine receptor antagonist, but it is pharmacologically unusual within its class because it also inhibits dopamine reuptake at the dopamine transporter, doing so by preferentially binding an inward-facing transporter conformation; this "atypical" binding mode is associated with markedly reduced cocaine-like subjective and locomotor effects and has made benztropine a template for candidate cocaine-dependence medications. Research has further highlighted its antagonism of M1 and M3 muscarinic receptors as a driver of oligodendrocyte differentiation and remyelination, prompting interest in multiple sclerosis and in protection against chemotherapy-induced peripheral neuropathy. Like other members of the deliriant anticholinergic family it produces a dangerous and unpleasant anticholinergic delirium at high doses rather than euphoria, so recreational use is discouraged.
- Treats Parkinsonism, especially tremor
- Relieves antipsychotic-induced extrapyramidal symptoms (dystonia, rigidity, parkinsonism)
- Can be given by injection for acute dystonic reactions
- Anticholinergic that also blocks dopamine reuptake atypically
- Dry mouth, blurred vision, constipation and urinary retention
- Confusion and memory problems, especially in the elderly
- Overheating from reduced sweating
- Delirium and hallucinations at high doses
Mechanism
Benztropine is a competitive at receptors (it sits on the receptor and stops acetylcholine from activating it). In Parkinsonism and antipsychotic-induced movement disorders, the therapeutic idea is to rebalance the tug-of-war between and acetylcholine signaling in the basal ganglia (a motor-control region), so damping down cholinergic tone eases tremor and rigidity. Unlike most anticholinergics, benztropine also inhibits the , blocking dopamine reuptake and raising dopamine. It additionally has some antihistamine (H1-blocking) activity, which adds to its sedating character. At high doses the widespread muscarinic blockade in the brain and body is what drives the classic anticholinergic toxidrome.
receptor fingerprint
receptors (M1-M5)Antagonist
()Reuptake inhibitor
H1 receptorAntagonist
Safetyrisks and cautions, not medical advice
This is a serious prescription drug, not a recreational one; at high doses benztropine causes anticholinergic delirium marked by realistic hallucinations that get mistaken for reality, confusion, and memory loss, alongside the full toxidrome: blurred vision, dangerous overheating, flushed dry skin, dry mouth, racing heart, urinary retention, seizures, and death. Stacking it with other anticholinergics (other deliriants, sedating antihistamines, tricyclics) adds up the anticholinergic burden and sharply raises the risk. In older people and with long-term use, high anticholinergic burden is associated with a higher risk of dementia. Not medical advice.
Interactionsdocumented pairs only, not exhaustive
Benztropine is a muscarinic antagonist, and its interactions are almost entirely additive anticholinergic burden. Combined with tricyclic antidepressants, low potency antipsychotics such as chlorpromazine, first generation antihistamines, oxybutynin or clozapine, the result can be confusion and frank anticholinergic delirium, particularly in older people.
Two consequences of that additive load are serious enough that the labeling calls them out. Paralytic ileus has occurred, sometimes fatally, in people taking benztropine alongside phenothiazines or tricyclics, and it can develop with little warning beyond vague abdominal complaints. Hyperthermia and heat stroke have occurred by the same route, because muscarinic blockade suppresses sweating; the risk rises in hot weather and with antipsychotics that already impair thermoregulation.
Slower gastric emptying from benztropine can also change how other drugs are absorbed, and its anticholinergic action works directly against prokinetics and against cholinesterase inhibitors such as donepezil, which are given for the opposite purpose.
Checking a whole stack? Run it through interactions + stacks.
Subjective profileweighing the evidence above
A useful prescription drug for drug-induced movement problems and a bad one to be curious about. High doses produce full anticholinergic delirium with overheating, seizures and death at the far end, and older adults pay for ordinary doses in confusion and memory.
Resources
This entry is here for reference.
Research
- 2011first citedThe binding sites for benztropines and dopamine in the dopamine transporter overlap
- 2021most recentAnticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in o…
- 1.Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia-Key Differences in Pathophysiology and Clinical Management
- 2.The binding sites for benztropines and dopamine in the dopamine transporter overlap
- 3.Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome
- 4.A regenerative approach to the treatment of multiple sclerosis.
- 5.Preventive action of benztropine on platinum-induced peripheral neuropathies and tumor growth.
- 6.Preference for distinct functional conformations of the dopamine transporter alters the relationship between subjective effects of cocaine and stimulation of mesolimbic dopamine.
- 7.Molecular dynamics of conformation-specific dopamine transporter-inhibitor complexes.
- 8.Novel C-1 substituted cocaine analogs unlike cocaine or benztropine.
8 listed here; entry last updated August 2026
Reviews
My notesprivate to this device
FAQ
Is benztropine a good recreational drug?
No. Like other deliriants it does not produce a pleasant high; high doses cause a frightening, confusing delirium with hallucinations mistaken for reality, plus a genuinely dangerous toxidrome.
Why does it help drug-induced movement problems?
Antipsychotics block dopamine, tipping the dopamine-acetylcholine balance in motor circuits. Benztropine blocks acetylcholine (and blocks dopamine reuptake) to help restore that balance.
What makes benztropine different from other anticholinergics?
On top of blocking muscarinic receptors it also inhibits dopamine reuptake, which is unusual for the class and part of why it is used in Parkinsonism.
Adverse effects
- Dry mouth, blurred vision, constipation and urinary retention
- Confusion and memory problems, especially in the elderly
- Overheating from reduced sweating
- Delirium and hallucinations at high doses